Skip to content

Updates

Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.

Food and Feed Litigation Regulatory Compliance and Enforcement Testimonial

We have advised a company on defending itself against an enforcement action brought by the Netherlands Food and Consumer Product Safety Authority (NVWA).

Food and Feed Medical Devices Pharmaceuticals Due Diligence Testimonial

Axon regularly acts as a sub-contractor for leading international firms to assist in regulatory due diligence in our fields of expertise: pharma, medical technology and food.

Biotech Food and Feed Due Diligence Regulatory Compliance and Enforcement Testimonial

Axon assisted a French VC company investing in a food tech start-up. We reviewed the target’s regulatory strategy under the EU novel foods framework, assessed its feasibility and outlined potential risks and how to mitigate these.

Litigation Testimonial

We have represented clients in complex commercial litigation proceedings, including claims relating to earn-out disputes in the context of corporate transactions in the life sciences sector.

Litigation Testimonial

Our firm litigates before the European Court of Justice on a variety of life sciences topics.

Medical Devices Litigation Testimonial

Our lawyers have acted as expert in national litigation cases on MDR compliance in other EU Member States.

Medical Devices Litigation Testimonial

One of our lawyers has acted as arbiter in international proceedings on MDR compliance.

Litigation Testimonial

Our firm is experienced in the conduct and defence of companies against freedom of information cases pertaining to confidential under Dutch and EU law, and has defended a number of companies, including a multinational, in a series of such cases over the years.

Healthcare Litigation Testimonial

We have assisted several clients in challenging tender decisions by Dutch hospitals.

Due Diligence Testimonial

Axon regularly provides specialist due diligence support on a variety of corporate transactions in the life sciences sector.